These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 10954656

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Anti-CD25 monoclonal antibody therapy affects the death signals of graft-infiltrating cells after clinical heart transplantation.
    Baan CC, Balk AH, van Riemsdijk IC, Vantrimpont PJ, Maat AP, Niesters HG, Zondervan PE, van Gelder T, Weimar W.
    Transplantation; 2003 May 27; 75(10):1704-10. PubMed ID: 12777860
    [Abstract] [Full Text] [Related]

  • 4. Resolution of endothelial activation and down-regulation of Tie2 receptor in psoriatic skin after infliximab therapy.
    Markham T, Mullan R, Golden-Mason L, Rogers S, Bresnihan B, Fitzgerald O, Fearon U, Veale DJ.
    J Am Acad Dermatol; 2006 Jun 27; 54(6):1003-12. PubMed ID: 16713454
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Humanized anti-CD25 antibody treatment with daclizumab in multiple sclerosis.
    Martin R.
    Neurodegener Dis; 2008 Jun 27; 5(1):23-6. PubMed ID: 18075271
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A pilot study on the use of the humanized anti-interleukin-2 receptor antibody daclizumab in active ulcerative colitis.
    Van Assche G, Dalle I, Noman M, Aerden I, Swijsen C, Asnong K, Maes B, Ceuppens J, Geboes K, Rutgeerts P.
    Am J Gastroenterol; 2003 Feb 27; 98(2):369-76. PubMed ID: 12591057
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Initial evaluation of subcutaneous daclizumab treatments for noninfectious uveitis: a multicenter noncomparative interventional case series.
    Nussenblatt RB, Peterson JS, Foster CS, Rao NA, See RF, Letko E, Buggage RR.
    Ophthalmology; 2005 May 27; 112(5):764-70. PubMed ID: 15878055
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Clinical experience with etanercept in the treatment of psoriasis].
    Martín B, Sánchez-Carazo JL, Pérez-Ferriols A, Laguna C, Oliver V, Alegre V.
    Actas Dermosifiliogr; 2008 Sep 27; 99(7):540-5. PubMed ID: 18682167
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Short-term anti-CD25 monoclonal antibody treatment and neogenetic CD4(+)CD25(high) regulatory T cells in kidney transplantation.
    Wang Z, Xiao L, Shi BY, Qian YY, Bai HW, Chang JY, Cai M.
    Transpl Immunol; 2008 Apr 27; 19(1):69-73. PubMed ID: 18346640
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A humanized monoclonal antibody against interleukin-2 that can inactivate the cytokine/receptor complex.
    Volkland J, Lumsden J, Mølhøj M, Raum T, Hausmann S, Wissing S, Wissinger M, Hoffmann P, Sriskandarajah M, Kvesic M, Baeuerle PA, Pflanz S.
    Mol Immunol; 2007 Mar 27; 44(7):1743-53. PubMed ID: 17000002
    [Abstract] [Full Text] [Related]

  • 20. [Analysis of lymphocyte populations in psoriatic plaques following inhibition of tumor necrosis factor alpha with etanercept].
    Mahiques L, Pitarch G, Sánchez-Carazo JL, Pérez-Ferriols A, Soriano CJ, Alegre V.
    Actas Dermosifiliogr; 2007 Oct 27; 98(8):539-44. PubMed ID: 17919428
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.